Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus.
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis*; D000917:Antibody Formation; D002474:Cell-Free System; D002645:Chickens / Q000276:immunology*; D006564:Herpesviridae / Q000276:immunology*; D008381:Herpesvirus 2, Gallid / Q000276:immunology; D007112:Immunity, Maternally-Acquired; D007279:Injections, Subcutaneous; D008380:Marek Disease / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D014422:Turkeys; D014765:Viral Vaccines / Q000008:administration & dosage*
D000914:Antibodies, Viral; D014765:Viral Vaccines